Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 19 Jan 2023 for Aveo Pharmaceuticals, INC., €581k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Anthony B. Evnin: trading record in brief
Anthony B. Evnin, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Infinity Pharmaceuticals, Inc., Aveo Pharmaceuticals, Inc. and Cantel Medical Corp. Between 2 June 2021 and 19 January 2023, the trades on record add up to 4 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 19 January 2023, reports a transaction of €581k in Aveo Pharmaceuticals, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Anthony B. Evnin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
41,841 shares@ US$15.00100.0% of flowCommon StockSEC:0000899243-23-002193:0
46,378 shares@ US$0.67963.4% of flowCommon StockSEC:0001140361-22-023338:0
3,061 shares@ US$3.4322.4% of flowCommon StockSEC:0001140361-21-020643:0
12,132 shares@ US$80.59100.0% of flowCommon Stock, par value $.10 per shareSEC:0001104659-21-075850:0
4 of 4 declarations
